S. 2333 118th Congress
Pandemic and All-Hazards Preparedness and Response Act
Latest action, Sep 6, 2023: Placed on Senate Legislative Calendar under General Orders. Calendar No. 202.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
3 cosponsors
Sponsored by Robert P. Casey, Jr. (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
0 D · 2 R · 1 I
- Democrat
- Republican
- Independent
Referred to: Senate: Health, Education, Labor, and Pensions Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
ALVOGEN
GREEN MOUNTAIN STRATEGIES LLC DC
7 reports
7 reports
7 reports
HEALTHCARE DISTRIBUTION ALLIANCE
GOVERNMENT COUNSEL, LLC
7 reports
7 reports
3M COMPANY
6 reports
AMERICAN COLLEGE OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
CASCADE ASSOCIATES
6 reports
6 reports
6 reports
AMERICAN HOSPITAL ASSOCIATION
THE NICKLES GROUP, LLC
6 reports
6 reports
AMGEN USA INC.
MARSHALL & POPP, LLC
6 reports
All 25 of 95 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| ALVOGEN | GREEN MOUNTAIN STRATEGIES LLC DC | 7 | $210K | Q4 2023 | Q3 2024 | yes |
| ASSOCIATION OF AMERICAN UNIVERSITIES | 7 | $436K | Q4 2023 | Q3 2024 | yes | |
| COLLEGE OF AMERICAN PATHOLOGISTS | 7 | $1.1M | Q4 2023 | Q3 2024 | yes | |
| HEALTHCARE DISTRIBUTION ALLIANCE | GOVERNMENT COUNSEL, LLC | 7 | $420K | Q4 2023 | Q3 2024 | yes |
| INFECTIOUS DISEASES SOCIETY OF AMERICA | 7 | $1.5M | Q4 2023 | Q3 2024 | yes | |
| MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY | 7 | $5.2M | Q4 2023 | Q3 2024 | yes | |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | 7 | $469K | Q4 2023 | Q3 2024 | yes | |
| 3M COMPANY | 6 | $1.9M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN COLLEGE OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE | CASCADE ASSOCIATES | 6 | $60K | Q4 2023 | Q3 2024 | yes |
| AMERICAN COLLEGE OF SURGEONS | 6 | $1.3M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION | 6 | $130K | Q4 2023 | Q3 2024 | yes | |
| AMERICAN FEDERATION OF TEACHERS | 6 | $1.8M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | THE NICKLES GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICAN LUNG ASSOCIATION | 6 | $640K | Q4 2023 | Q3 2024 | yes | |
| AMGEN USA INC. | MARSHALL & POPP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 6 | $3.8M | Q4 2023 | Q3 2024 | yes | |
| BAXTER HEALTHCARE CORPORATION | THE NICKLES GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | AKIN GUMP STRAUSS HAUER & FELD | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| CLEVELAND CLINIC FOUNDATION | THE NICKLES GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| CURE SMA | 6 | $450K | Q4 2023 | Q3 2024 | yes | |
| EMERGENT BIOSOLUTIONS | THE NICKLES GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| FLORIDA HOSPITAL ASSOCIATION | THE NICKLES GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| GENENTECH | THE MCMANUS GROUP | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| GENENTECH, INC. | MARSHALL & POPP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| GSK (FKA GLAXOSMITHKLINE INC.) | 6 | $7.3M | Q4 2023 | Q3 2024 | yes |